| Literature DB >> 33769697 |
Huan Liu1, Wenlong Lin1, Zhiyong Liu1, Yinjing Song2, Hao Cheng2, Huazhang An3, Xiaojian Wang1.
Abstract
Psoriasis is mainly characterized by abnormal hyperplasia of keratinocytes and immune cells infiltrating into the dermis and epidermis. Neural precursor cell expressed developmentally downregulated 4-like (NEDD4L) is a highly conserved HECT type E3 ligase that plays an important role in regulating physiological and pathological processes. Here, we identify NEDD4L as a negative regulator of psoriasis. Nedd4l significantly inhibits imiquimod (IMQ)-induced skin hyperplasia, and this effect is attributed to the inhibitory effect of NEDD4L on IL-6/GP130 signaling in keratinocytes. Mechanistically, NEDD4L directly interacts with GP130 and mediates its Lys-27-linked ubiquitination and proteasomal degradation. Moreover, the expression of NEDD4L is downregulated in the epidermis from IMQ-treated mice and psoriasis patients and negatively correlates with the protein levels of GP130 and p-STAT3 in clinical samples. Collectively, we uncover an inhibitory role of NEDD4L in the pathogenesis of psoriasis and suggest a new therapeutic strategy for the treatment of psoriasis.Entities:
Keywords: GP130; NEDD4L; hyperplasia; psoriasis; ubiquitination
Mesh:
Substances:
Year: 2021 PMID: 33769697 PMCID: PMC8097351 DOI: 10.15252/embr.202052063
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807